3rd annual Ft. Defiance Cancer Awareness Conference set for June 5
EurekAlert! Thu, 03 Jun 2010 14:02 PM PDT
( The Translational Genomics Research Institute ) A cancer conference dedicated to increased awareness about cancer among the Navajo people is helping bridge Western and Native American approaches to disease and treatments. |
Cancer Survivor Makes Dream Come True
WREG-TV Memphis Thu, 03 Jun 2010 14:01 PM PDT
When you are fighting a deadly disease it's easy to give up on a lot of things, including your dreams. However, that wasn't the case for one young Germantown man. 29-year-old Ryan Swanson beat cancer not once, but twice. And after three years of being cancer free, he's making a life long dream a reality. |
HomeAway Announces Passing of Chief Operating Officer, Andrew Harris
PR Newswire via Yahoo! Finance Thu, 03 Jun 2010 13:58 PM PDT
HomeAway®, Inc. regrets to announce Andrew Harris, the company's chief operating officer , passed away at his home in Austin on June 2, 2010, after a long and valiant battle with cancer.  The company extends its deepest condolences to Mr. |
ASGE issues guideline on ethnic issues in endoscopy
PhysOrg Thu, 03 Jun 2010 13:53 PM PDT
The American Society for Gastrointestinal Endoscopy (ASGE) has issued guidelines addressing ethnicity, gastrointestinal diseases and endoscopic procedures. The guideline suggests that colorectal cancer screening should begin at age 45 for average risk African-American men and women, and that it is recommended that colorectal cancer screening be emphasized for other minority ethnic groups that ... |
St. Jude Named Top Cancer Hospital
FOX 13 Memphis Thu, 03 Jun 2010 13:52 PM PDT
St. Jude has been named the nation's top children's cancer hospital in the nation by U.S. News and World Report. |
Meet Miracle Kid Hailey Coniber
News 10 NBC Rochester Thu, 03 Jun 2010 13:51 PM PDT
Before she was three years old, Hailey Coniber was twice diagnosed with cancer. She had six surgeries and a full round of chemotherapy... |
Lorus Therapeutics Announces Filing of Preliminary Short Form Prospectus
SYS-CON Media Thu, 03 Jun 2010 13:47 PM PDT
Lorus Therapeutics Inc. (TSX: LOR)(OTCBB: LRUSF) ("Lorus" or the "Company"), a biopharmaceutical company specializing in the research and development of pharmaceutical products and technologies for the management of cancer, announced today that it has filed a preliminary short form prospectus in the provinces of Ontario, Alberta and British Columbia and an amendment to the Registration Statement ... |
Bulldogs take up fight in support of Paula's Patriots
The North Bay Nugget Thu, 03 Jun 2010 13:45 PM PDT
One of Paula Palangio's dying wishes was for family and friends to get involved in supporting cancer research. The North Bay Bulldogs senior football team -- including many former employees of Palangio's at Cecil's Eatery and Beer Society -- has taken up the fight. This week, the Bulldogs [...] |
Novartis' Afinitor meets cancer study goals
San Francisco Chronicle Thu, 03 Jun 2010 13:44 PM PDT
Novartis AG said Thursday that its drug Afinitor met key treatment goals in a late-stage study on patients with neuroendocrine tumors in the pancreas. The company said Afinitor, combined with supportive care, extended the time patients survived without the... Cancer - Novartis - Health - Conditions and Diseases - Neuroendocrine tumor |
| |
|
No comments:
Post a Comment